Exploring how vaping prevention ads affect young people
Understanding the Impact of Vaping Prevention Ads on Adolescents and Young Adults
This study is looking at how well different vaping prevention videos work to stop teens and young adults from vaping, especially focusing on how these ads might affect LGBTQ+ youth who may be more at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10934535 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of vaping prevention video advertisements on adolescents and young adults, particularly focusing on how different features of these ads influence their perception and behavior. The study will analyze a large collection of vaping prevention ads to identify which elements are most impactful in reducing the likelihood of vaping among youth. Additionally, it will explore whether the effectiveness of these ads varies based on sexual orientation, especially among lesbian, gay, and bisexual individuals who may be at higher risk for vaping. Participants will include 3,000 adolescents and young adults aged 13-20, with a focus on those who are at risk of vaping.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults aged 13-20, particularly those who are at risk of vaping or identify as lesbian, gay, or bisexual.
Not a fit: Patients who are older than 20 or do not fall within the at-risk categories for vaping may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaping prevention campaigns that significantly reduce vaping rates among young people.
How similar studies have performed: While smoking prevention campaigns have shown success, the specific approach of analyzing vaping prevention ads is relatively novel and has not been extensively tested.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Noar, Seth Michael — Univ of North Carolina Chapel Hill
- Study coordinator: Noar, Seth Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.